13F
← All fund report cards

VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.

13F equity value
$11.4B
Positions
240
Top 10 concentration
41.0%
Quarters / total new picks
32 / 487
13F equity value over time
$0M$6B$12B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.0% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = -0.76, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.3%
t-stat
-0.76
Quarterly win rate
53%
Annualized excess
+2.1%
$1 → follow vs universe
$2.43 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.08720180630: follow 1.01820180930: follow 0.97520181231: follow 1.01520190331: follow 1.02120190630: follow 1.08020190930: follow 1.19220191231: follow 1.06120200331: follow 1.06420200630: follow 1.15720200930: follow 1.31720201231: follow 1.38420210331: follow 1.51420210630: follow 1.51420210930: follow 1.38120211231: follow 1.40220220331: follow 1.43720220630: follow 1.32920220930: follow 1.41520221231: follow 1.43220230331: follow 1.52920230630: follow 1.50820230930: follow 1.56020231231: follow 1.60720240331: follow 1.68720240630: follow 1.71520240930: follow 1.85820241231: follow 1.88820250331: follow 2.00720250630: follow 2.04620250930: follow 2.26620251231: follow 2.427 0.84 1.73 2.62 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 240 · 2026 Q1

Ticker Value Weight QoQ
MSFT $648M
5.7%
ADD
GOOGL $568M
5.0%
TRIM
BKNG $562M
4.9%
ADD
NXPI $543M
4.8%
ADD
MKL $433M
3.8%
ADD
META $431M
3.8%
ADD
KKR $402M
3.5%
ADD
BRO $383M
3.4%
ADD
AMZN $371M
3.3%
HOLD
LFUS $333M
2.9%
HOLD
SPOT $329M
2.9%
ADD
TSM $322M
2.8%
HOLD
CPAY $265M
2.3%
ADD
LEN $231M
2.0%
ADD
TMO $217M
1.9%
HOLD
CB $213M
1.9%
HOLD
PTC $209M
1.8%
ADD
NVDA $187M
1.6%
TRIM
V $180M
1.6%
HOLD
BRK/B $160M
1.4%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.